Body · Weight Loss
Ozempic (semaglutide) is a clinically proven, medically supervised weight loss treatment — helping patients lose 4–5 kg per month safely through appetite regulation, with zero significant side effects. Managed by Dr. Megha Sharma.
About This Treatment
Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist — originally developed for Type 2 diabetes — that has been proven highly effective for weight loss. It works by mimicking the natural GLP-1 gut hormone, signalling the brain to reduce appetite, slowing gastric emptying so you feel full longer, and reducing cravings for high-calorie foods.
At MS Skin Clinic, semaglutide is administered under Dr. Megha Sharma's medical supervision with regular monitoring. We use established brands: Zydus, Ozempic, and Wegovy. Dose is individualised based on body weight and tolerance, starting at 0.25 mg weekly and titrating upward.
How It Works
For Every Patient
FAQs
With diet management, patients typically lose 4–5 kg per month. Without active diet change, 2–3 kg per month is common. Results vary by individual metabolism and starting weight.
Semaglutide has an excellent safety profile with no significant long-term side effects. Mild nausea in the first 1–2 weeks is occasionally reported as the dose starts, but resolves quickly.
Yes. Semaglutide (Ozempic) is a GLP-1 agonist with a well-established long-term safety profile. Tirzepatide (Manjaro) is a newer dual agonist with some long-term safety concerns. We recommend semaglutide for its superior safety record.
Weight can return after stopping if lifestyle changes are not maintained. Dr. Megha Sharma discusses a comprehensive maintenance plan including diet, exercise, and appropriate medical strategy after the treatment course.
₹30,000 per month covering 4 weekly doses. This may vary by brand availability. Please contact us for current pricing.
Featured Videos
Free Consultation
Call us or WhatsApp — our team responds within 2 hours.
Or fill the form on our Contact page
